These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36067073)

  • 1.
    J Interferon Cytokine Res; 2023 Apr; 43(4):188. PubMed ID: 36067073
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to:
    J Interferon Cytokine Res; 2021 Nov; 41(11):435. PubMed ID: 34714133
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated Level of Serum Interleukin-21 and Its Influence on Disease Activity in Anti-Neutrophil Cytoplasmic Antibodies Against Myeloperoxidase-Associated Vasculitis.
    Xu J; Zhao H; Wang S; Zheng M; Shuai Z
    J Interferon Cytokine Res; 2022 Jun; 42(6):290-300. PubMed ID: 35416717
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    J Interferon Cytokine Res; 2022 Nov; 42(11):594. PubMed ID: 36383127
    [No Abstract]   [Full Text] [Related]  

  • 5. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
    Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
    [No Abstract]   [Full Text] [Related]  

  • 6. [The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis].
    Wang S; Zheng MJ; Zhou XL; Liu YQ; Shuai ZW
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):738-742. PubMed ID: 30293334
    [No Abstract]   [Full Text] [Related]  

  • 7. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
    Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
    Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    J Interferon Cytokine Res; 2022 Nov; 42(11):595. PubMed ID: 36346306
    [No Abstract]   [Full Text] [Related]  

  • 10. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
    Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
    Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    J Interferon Cytokine Res; 2024 Apr; 44(4):190. PubMed ID: 37566542
    [No Abstract]   [Full Text] [Related]  

  • 12. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
    Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
    [No Abstract]   [Full Text] [Related]  

  • 13. Correction to:
    J Interferon Cytokine Res; 2021 May; 41(5):195. PubMed ID: 34003683
    [No Abstract]   [Full Text] [Related]  

  • 14.
    J Interferon Cytokine Res; 2022 Apr; 42(4):191. PubMed ID: 35275748
    [No Abstract]   [Full Text] [Related]  

  • 15. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
    J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity.
    Nagai M; Hirayama K; Ebihara I; Shimohata H; Kobayashi M; Koyama A
    Nephron Clin Pract; 2011; 118(4):c339-45. PubMed ID: 21293157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus.
    Su F; Xiao W; Yang P; Chen Q; Sun X; Li T
    An Bras Dermatol; 2017; 92(4):466-469. PubMed ID: 28954092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial therapy for nontuberculous mycobacterial pulmonary disease improved hearing loss and normalized myeloperoxidase-anti-neutrophil cytoplasmic antibody level: A case report.
    Tomishima Y; Suda M; Tamaki H
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):283-287. PubMed ID: 35588087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Bornstein G; Ben-Zvi I; Furie N; Grossman C
    Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis.
    Ahn SS; Yoon T; Song JJ; Park YB; Lee SW
    In Vivo; 2021; 35(3):1761-1768. PubMed ID: 33910860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.